Kovai Medical Center & Hospital Ltd
Kovai Medical Center and Hospital Limited operates a multi-speciality hospital primarily in India. The company operates in two segments, Healthcare Services and Education Services. It operates various medical facilities, which provide services related to emergency and trauma care, cardiology, oncology, gynaecology and obstetrics, radiology, transplant, neurology, as well as orthopaedics and joint replacement, gastroenterology and haematology, pediatrics, endocrinology, diabetes management, rheumatology, pulmonology, psychiatry, cosmetic surgery, ENT, dermatology, hematology, urology, nephrology, and paediatrics. The company also offers preventive health check-ups and wellbeing programs. In addition, it operates a medical college in Coimbatore. The company serves out-patients, in-patients, and common public. Kovai Medical Center and Hospital Limited was incorporated in 1985 and is based in Coimbatore, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Healthy return on equity of 20.2%
Concerns1
- Negative free cash flow (βΉ197 Cr)
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ1.37 K Cr | β | βΉ209.00 Cr | β | β | 19.2% | 12.4% | 16.1% |
| Mar 2024 | βΉ1.22 K Cr | β | βΉ180.00 Cr | β | β | 20.2% | 19.6% | 55.2% |
| Mar 2023 | βΉ1.02 K Cr | β | βΉ116.00 Cr | β | β | 16.1% | 12.7% | 11.5% |
| Mar 2022 | βΉ905.00 Cr | β | βΉ104.00 Cr | β | β | 17.1% | 31.2% | 33.3% |
| Mar 2021 | βΉ690.00 Cr | β | βΉ78.00 Cr | β | β | 15.3% | -3.1% | -17.9% |
| Mar 2020 | βΉ712.00 Cr | β | βΉ95.00 Cr | β | β | 22.0% | 13.4% | 58.3% |
| Mar 2019 | βΉ628.00 Cr | β | βΉ60.00 Cr | β | β | 17.5% | 6.8% | 3.4% |
| Mar 2018 | βΉ588.00 Cr | β | βΉ58.00 Cr | β | β | 20.2% | 10.7% | -3.3% |
| Mar 2017 | βΉ531.00 Cr | β | βΉ60.00 Cr | β | β | 25.5% | 14.2% | 50.0% |
| Mar 2016 | βΉ465.00 Cr | β | βΉ40.00 Cr | β | β | 22.7% | 15.7% | 2.6% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 1,478 |
| Total Expenses | 1,061 |
| EBIT / Operating Profit | 417 |
| OPM % | 28% |
| Other Income | 25 |
| Finance Costs | 36 |
| Depreciation & Amortisation | 102 |
| Profit Before Tax | 304 |
| Tax % | - |
| Net Profit / PAT | 229 |
| EPS (βΉ) | 208.90 |
| Dividend Payout % | - |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Kovai Medical Center & Hospital Ltdthis co. | βΉ6.07 K Cr | βΉ1.37 K Cr | 26.60 | 5.10 | 17.23 | 12.4% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |